National Practice Patterns for Immediate Postoperative Instillation of Chemotherapy in Nonmuscle Invasive Bladder Cancer
Author:
Affiliation:
1. Department of Urologic Surgery, Vanderbilt University, Nashville, Tennessee
2. Genesis Health Partners, San Diego, California
3. Clarity Pharma Research, Spartanburg, South Carolina
4. Allergan, Irvine, California
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference9 articles.
1. Natural history of superficial bladder cancer;Heney;Urol Clin North Am,1992
2. Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy;Kassouf;Can Urol Assoc J,2010
3. The health economics of bladder cancer: a comprehensive review of the published literature;Botteman;Pharmacoeconomics,2003
4. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials;Sylvester;J Urol,2004
5. Clinical model of lifetime cost of treating bladder cancer and associated complications;Avritscher;Urology,2006
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Epirubicin and Non-Muscle Invasive Bladder Cancer Treatment: A Systematic Review;Journal of Clinical Medicine;2024-06-27
2. A phase 2 pilot study of water irrigation after transurethral resection of bladder tumor (WATIP) demonstrating safety, feasibility and activity;World Journal of Urology;2024-03-04
3. Effect of different infusion modes of pirarubicin on recurrence rate and adverse reactions in patients with postoperative chemotherapy for bladder cancer: A Meta-Analysis;2024-02-19
4. Association of Age with Non–muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?;European Urology Oncology;2024-02
5. Single-Dose Post-Office Fulguration Mitomycin C Instillation Appears to Improve Recurrence-Free Survival in Patients With Low-Grade Noninvasive Bladder Cancer;Clinical Genitourinary Cancer;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3